While human apoA-II deficiency was reported to have little influence on lipoprotein levels and the coronary artery disease risk [3], murine apoA-II deficiency caused HDL deficit in mice [4], suggesting that the effect of apoA-II on HDL is quite different in humans and mice. Here, APOA2 is linked to coronary artery disorder.